CLPT vs RSW.L
CLPT: ClearPoint Neuro provides advanced image-guided navigation and delivery platforms to enable precise, minimally invasive neurosurgical procedures. RSW.L: A world leader in high-precision measurement, motion control, and additive manufacturing technologies serving the global industrial and healthcare sectors.
Side-by-side fundamentals
| Metric | CLPT | RSW.L | Edge |
|---|---|---|---|
| Price as of 2026-08-21 close | $15.39 | £50.05 | |
| Market cap as of 2026-08-24 | $469M | n/a | |
| PEG as of 2026-08-24 | -0.27 | n/a | |
| Net margin as of 2026-08-24 | -71.6% | n/a | |
| Gross margin as of 2026-08-24 | +62.3% | n/a | |
| Operating margin as of 2026-08-24 | -65.2% | n/a | |
| ROE as of 2026-08-24 | -141.0% | n/a | |
| ROA as of 2026-08-24 | -37.0% | n/a | |
| Debt / equity as of 2026-08-24 | 2.63 | n/a | |
| Revenue growth (YoY) as of 2026-08-24 | +26.0% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +21.6% | n/a | |
| Beta as of 2026-08-24 | 1.23 | n/a | |
| 1-year return as of 2026-08-21 close | +50.3% | +68.2% | RSW.L higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.